A

Aprea Therapeutics
D

APRE

2.90000
USD
-0.11
(-3.65%)
مغلق
حجم التداول
5
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
15,761,219
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    APTX
    0
    (0%)
    0.000000 USD
    A
    ARVN
    -2.440
    (-9.78%)
    22.500 USD
    A
    ASND
    2.160
    (1.74%)
    126.510 USD
    A
    ATRA
    -0.830
    (-6.45%)
    12.030 USD
    A
    AUTL
    0.07000
    (2.33%)
    3.08000 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    B
    BPMC
    -6.990
    (-7.31%)
    88.690 USD
    C
    CRNX
    -4.900
    (-8.21%)
    54.790 USD
    المزيد
الأخبار

العنوان: Aprea Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.